BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9894)

  • 1. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is it possible to envisage the treatment of various potentially dangerous states with prolonged-action chemotherapy?].
    Boissenin JM; Staël P; Poiré R
    Ann Med Psychol (Paris); 1970 May; 128(5):776-81. PubMed ID: 5452656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of severe psychotic outbreaks by short-interval injection of pipothiazine undecylenate].
    Tignol J; Dartigues JF; Daubech JF; Bourgeois M
    Ann Med Psychol (Paris); 1979; 137(3-4):345-51. PubMed ID: 40513
    [No Abstract]   [Full Text] [Related]  

  • 10. [7 years of experience with delayed action neuroleptics].
    Noguera Hosta R; Rendueles de Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
    La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oral and injectable phenothiazines in treatment of psychotic patients.
    Yorke ET
    Dis Nerv Syst; 1967 Oct; 28(10):667-70. PubMed ID: 4860894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Withdrawal of delayed-action neuroleptics in psychotic patients].
    Maillard M; Coutanceau R; Marchina JC
    Ann Med Psychol (Paris); 1979; 137(3-4):351-5. PubMed ID: 40514
    [No Abstract]   [Full Text] [Related]  

  • 17. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K; Rodová A; Svestka J
    Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
    [No Abstract]   [Full Text] [Related]  

  • 20. A brief history of depot neuroleptics.
    Simpson GM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):3-4. PubMed ID: 6143745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.